Content area
Abstract
Cataldo, Nixon, and their colleagues tracked these endosomal abnormalities back to an Alzheimer's associated mutation of the amyloid precursor protein (APP) gene. Cataldo had also begun to investigate presenilin mutations and APP signalling, and was in the early stages of looking at whether modification of mesenchymal stem cells to deliver growth factors to the brain could prevent nerve cell destruction.